Paykel Neela
Known title: Gen Counsel & Corp SecretaryCIK: 0001894593
Associated companies
Transaction History
| HYPR | ▼ Sell | Open Market | 1,895 | $2K | 11/16/2022 | View on chart |
| HYPR | ▼ Sell | Open Market | 1,891 | $3K | 8/15/2022 | View on chart |
| HYPR | ▼ Sell | Open Market | 10,542 | $21K | 7/5/2022 | View on chart |
| HYPR | ▲ Buy | Grant | 85,000 | $0 | 3/29/2022 | View on chart |
| HYPR | ▲ Buy | Grant | 42,500 | $0 | 3/29/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Hyperfine Expands Portable Brain MRI Reach to Gulf Markets
Hyperfine has announced that its portable brain MRI system will now be available in key Gulf Cooperation Council countries, expanding its global footprint. The move follows the company’s recent rollout in other international markets and could increase adoption in the region’s hospitals. BTIG has reiterated a bullish stance, keeping its $2 price target unchanged. These developments highlight growing interest in Hyperfine’s technology.
Hyperfine Expands Portable Brain MRI Reach to Gulf Markets. Hyperfine has announced that its portable brain MRI system will now be available in key Gulf Cooperation Council countries, expanding its global footprint. The move follows the company’s recent rollout in other international markets and could increase adoption in the region’s hospitals. BTIG has reiterated a bullish stance, keeping its $2 price target unchanged. These developments highlight growing interest in Hyperfine’s technology.